MediGene AG

MediGene AG
Stock Exchange Other OTC
EPS
$0.91
Market Cap
$204.19 M
Shares Outstanding
24.55 M
Public Float
-

Profile

Address
Lochhamer Straße 11
Martinsried Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.medigene.de
Updated 07/08/2019
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments.

Financials

View All

Horst Domdey
Chairman-Supervisory Board
Gerd Zettlmeissl
Member-Supervisory Board